Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2023-06-28 00:00:00 ET · period of report 2023-06-26 · accession 0001209191-23-040105 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-06-28 | 2023-06-26+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.61 | +46.8K | 544.0K | +9% | +$28.5K |
| DM | 2023-06-28 | 2023-06-26+ | TYRA | Bensen Daniel | COO | S - Sale+OE | $16.86 | -46.8K | 536.1K | -8% | -$788.7K |
| DM | 2023-06-28 | 2023-06-26+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.00 | -46.8K | 182.3K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-26 | M | A | 17,232 | $0.61 | 545,213 | D | — | — | |
| 2 | Common | Common Stock | 2023-06-26 | S | D | 10,862 | $16.49 | 534,351 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.01 to $17.005. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 3 | Common | Common Stock | 2023-06-28 | S | D | 13,524 | $16.91 | 527,981 | D | — | — | (F6) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.50 to $17.09. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 4 | Common | Common Stock | 2023-06-28 | M | A | 13,524 | $0.61 | 541,505 | D | — | — | |
| 5 | Common | Common Stock | 2023-06-27 | S | D | 8,135 | $17.09 | 527,981 | D | — | — | (F5) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.02 to $17.20. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 6 | Common | Common Stock | 2023-06-26 | S | D | 6,370 | $17.24 | 527,981 | D | — | — | (F3) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.02 to $17.69. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 7 | Common | Common Stock | 2023-06-27 | M | A | 16,028 | $0.61 | 544,009 | D | — | — | |
| 8 | Common | Common Stock | 2023-06-27 | S | D | 7,893 | $16.73 | 536,116 | D | — | — | (F4) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.01 to $17.01. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 9 | Derivative | Stock Option (Right to Buy) | 2023-06-27 | M | D | 16,028 | $0.00 | 195,802 | D | $0.61 · — to 2030-01-26 | 16,028 Common Stock | (F7) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. |
| 10 | Derivative | Stock Option (Right to Buy) | 2023-06-26 | M | D | 17,232 | $0.00 | 211,830 | D | $0.61 · — to 2030-01-26 | 17,232 Common Stock | (F7) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. |
| 11 | Derivative | Stock Option (Right to Buy) | 2023-06-28 | M | D | 13,524 | $0.00 | 182,278 | D | $0.61 · — to 2030-01-26 | 13,524 Common Stock | (F7) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. |